198 related articles for article (PubMed ID: 16524944)
1. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells.
Aboody KS; Najbauer J; Schmidt NO; Yang W; Wu JK; Zhuge Y; Przylecki W; Carroll R; Black PM; Perides G
Neuro Oncol; 2006 Apr; 8(2):119-26. PubMed ID: 16524944
[TBL] [Abstract][Full Text] [Related]
2. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
[TBL] [Abstract][Full Text] [Related]
3. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
[TBL] [Abstract][Full Text] [Related]
4. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma.
Shimato S; Natsume A; Takeuchi H; Wakabayashi T; Fujii M; Ito M; Ito S; Park IH; Bang JH; Kim SU; Yoshida J
Gene Ther; 2007 Aug; 14(15):1132-42. PubMed ID: 17508009
[TBL] [Abstract][Full Text] [Related]
5. Active specific immunotherapy against occult brain metastasis.
Lu W; Su J; Kim LS; Bucana CD; Donawho C; He J; Fidler IJ; Dong Z
Cancer Res; 2003 Mar; 63(6):1345-50. PubMed ID: 12649197
[TBL] [Abstract][Full Text] [Related]
6. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
7. Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant.
Randazzo BP; Kesari S; Gesser RM; Alsop D; Ford JC; Brown SM; Maclean A; Fraser NW
Virology; 1995 Aug; 211(1):94-101. PubMed ID: 7645240
[TBL] [Abstract][Full Text] [Related]
8. Reduction of brain injury in neonatal hypoxic-ischemic rats by intracerebroventricular injection of neural stem/progenitor cells together with chondroitinase ABC.
Sato Y; Nakanishi K; Hayakawa M; Kakizawa H; Saito A; Kuroda Y; Ida M; Tokita Y; Aono S; Matsui F; Kojima S; Oohira A
Reprod Sci; 2008 Jul; 15(6):613-20. PubMed ID: 18579850
[TBL] [Abstract][Full Text] [Related]
9. Reactive astrogliosis induces astrocytic differentiation of adult neural stem/progenitor cells in vitro.
Faijerson J; Tinsley RB; Apricó K; Thorsell A; Nodin C; Nilsson M; Blomstrand F; Eriksson PS
J Neurosci Res; 2006 Nov; 84(7):1415-24. PubMed ID: 16998910
[TBL] [Abstract][Full Text] [Related]
10. Isolation, characterization and gene modification of fetal neural stem/progenitor cells from cynomolgus monkey.
Wang P; Liu XM; Liu XM; Ma BF; Jia L; Wang D; Zhang XM; Yu XB; Lahn BT; Xiang AP
Neuroreport; 2008 Mar; 19(4):419-24. PubMed ID: 18287939
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy of experimental brain tumors using neural progenitor cells.
Benedetti S; Pirola B; Pollo B; Magrassi L; Bruzzone MG; Rigamonti D; Galli R; Selleri S; Di Meco F; De Fraja C; Vescovi A; Cattaneo E; Finocchiaro G
Nat Med; 2000 Apr; 6(4):447-50. PubMed ID: 10742153
[TBL] [Abstract][Full Text] [Related]
12. Brain metastases of melanoma--mechanisms of attack on their defence system by engineered stem cells in the microenvironment.
Dimitrov BD; Atanassova PA; Rachkova MI
J Zhejiang Univ Sci B; 2007 Sep; 8(9):609-11. PubMed ID: 17726739
[TBL] [Abstract][Full Text] [Related]
13. Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
Cruz-Munoz W; Man S; Xu P; Kerbel RS
Cancer Res; 2008 Jun; 68(12):4500-5. PubMed ID: 18559492
[TBL] [Abstract][Full Text] [Related]
14. Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia.
Kameda M; Shingo T; Takahashi K; Muraoka K; Kurozumi K; Yasuhara T; Maruo T; Tsuboi T; Uozumi T; Matsui T; Miyoshi Y; Hamada H; Date I
Eur J Neurosci; 2007 Sep; 26(6):1462-78. PubMed ID: 17880388
[TBL] [Abstract][Full Text] [Related]
15. Stem-cell based therapies for brain tumors.
Yip S; Shah K
Curr Opin Mol Ther; 2008 Aug; 10(4):334-42. PubMed ID: 18683097
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell-derived bone morphogenetic proteins control proliferation of neural stem/progenitor cells.
Mathieu C; Sii-Felice K; Fouchet P; Etienne O; Haton C; Mabondzo A; Boussin FD; Mouthon MA
Mol Cell Neurosci; 2008 Aug; 38(4):569-77. PubMed ID: 18583149
[TBL] [Abstract][Full Text] [Related]
17. Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury.
Kimura A; Ohmori T; Ohkawa R; Madoiwa S; Mimuro J; Murakami T; Kobayashi E; Hoshino Y; Yatomi Y; Sakata Y
Stem Cells; 2007 Jan; 25(1):115-24. PubMed ID: 16990586
[TBL] [Abstract][Full Text] [Related]
18. The new challenge of stem cell: brain tumour therapy.
Colleoni F; Torrente Y
Cancer Lett; 2008 Dec; 272(1):1-11. PubMed ID: 18621474
[TBL] [Abstract][Full Text] [Related]
19. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
20. Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma.
Dickson PV; Hamner JB; Burger RA; Garcia E; Ouma AA; Kim SU; Ng CY; Gray JT; Aboody KS; Danks MK; Davidoff AM
J Pediatr Surg; 2007 Jan; 42(1):48-53. PubMed ID: 17208540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]